Charl van Zyl
Chief Executive Officer at H. LUNDBECK A/S
Profile
Mr. Charl van Zyl is an Executive Vice President-Neurology Solutions at UCB SA. He is on the Board of Directors at Ra Pharmaceuticals, Inc. and UCB Celltech. Mr. van Zyl was previously employed as an Executive Vice President by BSN Medical SA, an Executive Vice President & Commercial Leader-EMEA by Bausch & Lomb Holdings, Inc., an Executive Vice President by Bausch + Lomb, Inc., a Chief Executive Officer by JADO Technologies GmbH, a Head-Sales & Marketing by Novartis AG, and a Marketing Manager by Eli Lilly & Co. He received his undergraduate degree from the University of Cape Town.
Charl van Zyl active positions
Companies | Position | Start |
---|---|---|
UCB | Corporate Officer/Principal | 2020-01-31 |
RA PHARMACEUTICALS, INC. | Director/Board Member | 2020-04-01 |
H. LUNDBECK A/S | Chief Executive Officer | 2023-09-30 |
UCB Celltech
UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The private company is based in Slough, UK and was founded in 2006. | Director/Board Member | 2017-05-09 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Former positions of Charl van Zyl
Companies | Position | End |
---|---|---|
BSN Medical SA
BSN Medical SA Pharmaceuticals: MajorHealth Technology BSN medical is a multinational company and one of the world leaders in producing and distributing medical products in the segments of plaster, bandages, wound care and compression therapy. Some of its brands are well known - Gypsona ®, Delta-Cast ®, Jobst ® and Tricodur ® - these are vetrouwde names in the medical industry. They have production sites in France, Germany, Mexico, Pakistan, South Africa, United Kingdom and the United States. Sales and marketing its products in major markets by BSN Medical themselves represented as a separate entity. BSN Medical employs approximately 3400 people and has a global turnover of more than 605 million Euros in 2009. BSN medical in April 2001 emerged from a 50:50 joint venture between the companies Beiersdorf AG, Hamburg, and Smith & Nephew plc, London. Purpose of this joint venture was the grouping of geographic and channel strengths in wound care, fracture treatment, physiotherapy and phebologie. | Corporate Officer/Principal | 2016-12-31 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Corporate Officer/Principal | 2012-12-31 |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | Chief Executive Officer | 2008-12-31 |
NOVARTIS AG | Sales & Marketing | 2006-12-31 |
░░░ ░░░░░ ░░░ ░░░░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Training of Charl van Zyl
University of Cape Town | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
H. LUNDBECK A/S | Health Technology |
NOVARTIS AG | Health Technology |
UCB | Health Technology |
Private companies | 7 |
---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Bausch & Lomb Holdings, Inc.
Bausch & Lomb Holdings, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb Holdings, Inc. developed, manufactured, and sold eye health products. Its products included contact lenses, contact lens care solutions, ophthalmic pharmaceuticals, and surgical products. The company was founded on September 25, 2009 and was headquartered in Rochester, NY. | Health Technology |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | Retail Trade |
BSN Medical SA
BSN Medical SA Pharmaceuticals: MajorHealth Technology BSN medical is a multinational company and one of the world leaders in producing and distributing medical products in the segments of plaster, bandages, wound care and compression therapy. Some of its brands are well known - Gypsona ®, Delta-Cast ®, Jobst ® and Tricodur ® - these are vetrouwde names in the medical industry. They have production sites in France, Germany, Mexico, Pakistan, South Africa, United Kingdom and the United States. Sales and marketing its products in major markets by BSN Medical themselves represented as a separate entity. BSN Medical employs approximately 3400 people and has a global turnover of more than 605 million Euros in 2009. BSN medical in April 2001 emerged from a 50:50 joint venture between the companies Beiersdorf AG, Hamburg, and Smith & Nephew plc, London. Purpose of this joint venture was the grouping of geographic and channel strengths in wound care, fracture treatment, physiotherapy and phebologie. | Health Technology |
UCB Celltech
UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The private company is based in Slough, UK and was founded in 2006. | Health Technology |
- Stock Market
- Insiders
- Charl van Zyl